Skip to main content
Clinical Trials/NCT02160938
NCT02160938
Completed
Not Applicable

Prenatal Cytogenetic Diagnosis by Array-Based Copy Number Analysis: Follow-Up

Columbia University9 sites in 1 country184 target enrollmentFebruary 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Genetic Diseases
Sponsor
Columbia University
Enrollment
184
Locations
9
Primary Endpoint
Full Scale Intelligence Quotient (IQ) score
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

The objectives of this multi-center collaborative study are to ascertain the frequency of specific copy number variants (CNVs) identified prenatally and to evaluate in detail through continued follow-up of the children the phenotypes associated with CNVs of known or uncertain clinical significance.

Detailed Description

Specifically the aims are as follows: 1. Determine the intellectual function of the children at age 3 years 2. Determine phenotypic characteristics other than intellectual function of the children at age 3 years 3. Determine the frequency of specific copy number variants discovered during routine prenatal diagnostic testing 4. Evaluate the educational, counseling and psychosocial implications of microarray testing as it is introduced as a standard prenatal diagnostic procedure.

Registry
clinicaltrials.gov
Start Date
February 2013
End Date
December 2018
Last Updated
7 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ronald J Wapner, MD

Professor and Vice Chairman for Research, Department of Obstetrics and Gynecology

Columbia University

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Full Scale Intelligence Quotient (IQ) score

Time Frame: age 3 years

Full Scale IQ score from the Wechsler Preschool and Primary Scale of Intelligence IV or Wechsler Intelligence Scale for Children 5th edition

Secondary Outcomes

  • Percent of subjects with cerebral palsy(age: up to 3 years)
  • Percent of subjects with specific commonly occurring CNVs(detected prenatally)
  • Percent of subjects with seizure disorders(age: up to 3 years)
  • Percent of subjects with dysmorphic features diagnosed by dysmorphologist(age 3 years)
  • Percent of subjects with structural anomalies(age: up to 3 years)
  • Verbal Comprehension composite score(age: up to 3 years)
  • Visual Spatial composite score(age: up to 3 years)
  • Age-adjusted Z scores for birth weight(birth)
  • Daily Living Skills domain score(age: up to 3 years)
  • Age-adjusted Z scores for birth length(birth)
  • Working Memory composite score(age: up to 3 years)
  • Communication domain score(age: up to 3 years)
  • Socialization domain score(age: up to 3 years)
  • Motor Skills domain score(age: up to 3 years)
  • Adaptive Behavior Composite score(age: up to 3 years)
  • Age-adjusted Z scores for head circumference(birth)

Study Sites (9)

Loading locations...

Similar Trials